Randomized controlled trials with statistically nonsignificant results

JAMA

Volumn 304, Issue 9, 2010, Pages 965-

  Allison, David B ^a   Cope, Mark B ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Solae Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSOCIATION; CLINICAL STUDY; CONTROL GROUP; FUNDING; HUMAN; LETTER; PRIORITY JOURNAL; PUBLISHING; STATISTICAL SIGNIFICANCE; CONFLICT OF INTEREST; DRUG INDUSTRY; ECONOMICS; ETHICS; FINANCIAL MANAGEMENT; NOTE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

CONFLICT OF INTEREST; DRUG INDUSTRY; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH SUPPORT AS TOPIC; TREATMENT OUTCOME;

EID: 77956201193     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.1245     Document Type: Letter

References (3)

1. Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA. 2010;303(20):2058-2064.
2. Cope MB, Allison DB. White hat bias: examples of its presence in obesity research and a call for renewed commitment to faithfulness in research reporting. Int J Obes (Lond). 2010;34(1):84-88.
3. Thomas O, Thabane L, Douketis J, Chu R, Westfall AO, Allison DB. Industry funding and the reporting quality of large long-term weight loss trials. Int J Obes (Lond). 2008;32(10):1531-1536.